Skip to content
Screener

AngioDynamics ANGO Common Stock

Common Stock at other companies

Abbott logo
AbbottABT
2.4B-90.5%
TFX
TeleflexTFX
$48.2M+0.2%
Stryker logo
StrykerSYK
$38M0.0%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$769.27M+7.1%
ICU Medical logo
ICU MedicalICUI
80M0.0%
Penumbra logo
PenumbraPEN
$39K0.0%

Other financials

Income statement

See full
Revenue$86.6M+8.0%
Gross profit$46.8M+10.8%
Operating income-$10.2M-76.1%
Net income-$11.4M-88.5%
EPS (diluted)-$0.27-80.0%

Balance sheet

See full
Cash & equivalents$53.9M-3.6%
Total debt$11.0M+8.0%
Total equity$170.8M-6.6%
Total assets$267.2M-4.6%

Cash flow

See full
Operating cash flow$17.5M
CapEx$413.0K-46.8%
Free cash flow$17.0M

Valuation

See full
Market cap$648.51M+88.9%
Enterprise value$605.6M+103%
P/S+0.9×

Profitability

See full
Gross margin54.6%+0.7pp
Operating margin-12.5%-1.0pp
Net margin-11.5%-0.1pp
FCF margin0.2%

Returns & leverage

See full
Return on equity-20.8%+4.8pp
Debt / equity0.1×0.0×
Current ratio2.2×0.0×

Where this comes from

Reported directly by AngioDynamics in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The source filing: AngioDynamics’s 10-K, filed July 14, 2026.

Filed
Jul 14, 2026, 3:42 PM EDT
Fiscal year
FY2026
Accession
0001628280-26-048138
Line itemMay 31, 2026May 31, 2025
Commitments and Contingencies (Note 17)
Stockholders’ Equity
Preferred stock, par value $0.01 per share, 5,000,000 shares authorized; no shares issued and outstanding
Common stock, par value $0.01 per share, 75,000,000 shares authorized; 42,314,266 and 41,607,877 shares issued and 41,700,419 and 40,994,030 shares outstanding at May 31, 2026 and 2025, respectively387385
Additional paid-in capital636,083621,186
Accumulated deficit(465,939)(429,197)
Treasury stock, 613,847 shares, at cost at May 31, 2026 and 2025, respectively(7,381)(7,381)
Accumulated other comprehensive loss7,675(2,023)

Item 15. Exhibits, Financial Statement Schedules.

FAQ

What is AngioDynamics's common stock?
AngioDynamics (ANGO) reported common stock of $387K in Q1 2026.
How has AngioDynamics's common stock changed year-over-year?
AngioDynamics's common stock increased by 0.5% year-over-year, from $385K to $387K.
What is the long-term trend for AngioDynamics's common stock?
Over 5 years (2021 to 2026), AngioDynamics's common stock has grown at a 0.5% compound annual growth rate (CAGR), from $377K to $387K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Ask your AI about AngioDynamics's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude